Top Markets
Coin of the day
Lipum AB (publ) Lipum AB (publ)

Lipum AB (publ)

LIPUM
株式のランク #27264
Lipum AB (publ) is a biopharmaceutical firm based in Sweden, focused on... Lipum AB (publ) is a biopharmaceutical firm based in Sweden, focused on pioneering the discovery and development of therapeutic solutions for long-term inflammatory conditions. The company's primary therapeutic asset, SOL-116, is a humanized antibody currently in the late preclinical stage, designed to treat pediatric rheumatism and adult rheumatoid arthritis. To facilitate the advancement of SOL-116 into clinical trials, Lipum has established a collaboration with Pelago Bioscience AB to meticulously monitor drug targets. Founded in 2010, the company's operations are headquartered in Umeå, Sweden.
株価
$1.60
最終同期: 2026-03-18
時価総額
$34.00M
変化(1日)
0.70%
変化(1年)
2.50%
SE
取引 Lipum AB (publ) (LIPUM)

カテゴリー

Lipum AB (publ)(LIPUM)の配当利回りの履歴
Lipum AB (publ)(銘柄コード: LIPUM)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Lipum AB (publ)(LIPUM)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)